Podcast appearances and mentions of george daley

The CBC's Jacques Poitras spoke with former education minister Dominic Cardy about the recent firing of deputy minister George Daley.

In this episode, I converse with Dr. Rubul Mout, a Research Fellow at Harvard Medical School and at the Stem Cell Program, Boston Children's Hospital (BCH). Born, brought up, and educated in India, Dr. Mout moved to the United States to pursue his PhD from the University of Massachusetts, Amherst. Prior to joining Harvard/BCH, he was a Washington Research Foundation Innovation Fellow at the Institute for Protein Design, University of Washington. Dr. Mout is the inventor of numerous technologies in gene editing and protein design, and in the last decade he developed a technology for intracellular protein delivery and gene editing in mammalian cells, termed as the ‘E-tag' method, which was in 2020, granted a patent by USPTO (the United States Patent and Trademark Office). At Harvard/BCH, Dr. Mout works to engineer bone marrow stem cells (Hematopoietic stem cells, or HSCs) to cure genetic diseases of blood origin and uses various technologies, including techniques he invented in his prior research, to engineer these HSCs. In particular, he uses patient-derived induced pluripotent stem cells (iPSC) to differentiate them to HSC first, and then to produce and train T-cells that could potentially fight off many diseases. We indulge in a terrific conversation on his magnificent journey through science and life inspired by his innate curiosity; growing up in a poor peasant's family in a far remote corner of Northeast India, near the Assam-Arunachal border; undertaking a majestic quest from Tinsukia to Mumbai to Amherst to Seattle to Boston; inspirational mentors like GK Johori, David Baker, Vincent Rotello, and George Daley; fantastic dedication to scientific outreach and activism; writing outstanding books including a popular bestseller that chronicled his splendid journey; and many more things!!

“Science transcends politics,” says Dr. George Daley. “My hope is that physicians and scientists will, in fact, be a force for global harmony, and that will be a silver lining to come out of the pandemic.” In this important conversation with Shiv Gaglani, Dr. Daley, who is an internationally recognized leader in stem cell science and cancer biology, describes his collaboration with recent Nobel laureate Jennifer Doudna and others to call for restraint in experimentation with stem cell technology, decries the current tension between the U.S. government and the scientific community. He also shares how, in response to COVID-19, he and his team were able to connect and mobilize disparate research communities -- including Chinese and European colleagues -- to develop the Massachusetts Consortium on Pathogen Readiness. Tune in to hear more about these critical topics and discover Dr. Daley's circuitous path to medicine and his perspective on COVID as a defining experience for this generation.

Most students will be going back to class tomorrow, for the first time in 6 months.  We talk to the deputy minister of education, George Daley about what has been done to prepare.

The phone in continues, with George Daley and David McTimoney answering your questions about the return to school.

Gregg Ingersoll is superintendent of the Anglophone East District South. George Daley is deputy minister of education and early childhood development.

Samantha Morris, Ph.D. is an Assistant Professor of Genetics and Developmental Biology at Washington University in St. Louis. She established her research group in 2015, focusing on developing new single-cell experimental and computational approaches to dissect mechanisms of cell fate reprogramming. Sam trained at the University of Cambridge with Magdalena Zernicka-Goetz, investigating early mammalian fate specification. She then joined the laboratory of George Daley at Harvard Medical School, where she focused on the analysis of gene regulatory networks to dissect and engineer cell identity. Together with her group, she continues in pursuit of her goal to engineer clinically relevant cell populations, translating new insights in cell fate specification into better models of disease and development.

Samantha Morris, Ph.D. is an Assistant Professor of Genetics and Developmental Biology at Washington University in St. Louis. She established her research group in 2015, focusing on developing new single-cell experimental and computational approaches to dissect mechanisms of cell fate reprogramming. Sam trained at the University of Cambridge with Magdalena Zernicka-Goetz, investigating early mammalian fate specification. She then joined the laboratory of George Daley at Harvard Medical School, where she focused on the analysis of gene regulatory networks to dissect and engineer cell identity. Together with her group, she continues in pursuit of her goal to engineer clinically relevant cell populations, translating new insights in cell fate specification into better models of disease and development.

Dr. George Daley is dean of the Faculty of Medicine at Harvard Medical School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. G.Q. Daley, R. Lovell-Badge, and J. Steffann. After the Storm — A Responsible Path for Genome Editing. N Engl J Med 2019;380:897-899.

Investigadores de la Universidad de Harvard presentaron en un simposio dedicado a la Biología Regenerativa trabajos pioneros que están en marcha para ser aplicados en la medicina. “Estamos en el epicentro del mundo en lo que significa saber cómo usar el poder de las células madre para el tratamiento de enfermedades”, dice Douglas Melton, profesor de la universidad. George Daley, decano de la Facultad de Medicina, describe el enorme trabajo para lograr modificar mediante la ingeniería, células madre humanas de la sangre para crear un donante universal que no dispare ningún ataque del sistema inmunológico. En el tratamiento de la diabetes, el uso de la terapia celular podría llevar a prescindir de la insulina inyectada. El trabajo consiste en convertir las células madre humanas en células pancreáticas beta, que serán productoras de insulina y que podrán ser usadas para tratar la diabetes.

Professor Karl Moore sits down with George Daley, Dean of Harvard Medical School, to discuss his career, his approach to leadership, and the evolution of medical school.

Guest For this episode, we bring on internationally recognized stem cell pioneer Dr. George Daley from Children’s Hospital Boston and the Harvard Stem Cell Institute to discuss all things stem cells. Resources and Links New…